Naltrexone Treatment Centers in Tennessee

Yes. Providers in Tennessee must document a current OUD diagnosis to prescribe naltrexone as part of medication-assisted treatment. The intake assessment typically takes 60–90 minutes and includes a physical exam, drug screen, and psychiatric history — results are used to confirm eligibility.

Yes. Tennessee MAT costs typically decrease as you stabilize — fewer in-person dosing visits, less frequent drug testing, and the option for take-home doses for methadone patients. Naltrexone patients often shift from monthly visits to quarterly visits once stable.

Yes. TennCare reimburses telehealth buprenorphine visits at parity with in-person visits in Tennessee; methadone induction still generally requires an in-person visit due to federal OTP rules. Follow-up methadone counseling can be telehealth.

Yes. Both UnitedHealthcare and Aetna cover the MAT benefit in Tennessee, including naltrexone. Verify in-network providers and whether long-acting injectables require prior authorization; patient-advocate lines can confirm network status before you schedule.

Clinics maintain a confidential medical record covering diagnosis, treatment plan, drug screens, counseling notes, and dose history. Records are protected by 42 CFR Part 2 — stricter than HIPAA — and cannot be released without your written consent or a specific court order.

Stability criteria include consistent attendance, clean drug screens, improved functioning, stable housing and relationships, and no recent crisis. Tennessee clinicians use SAMHSA’s 8-point take-home criteria for methadone and similar frameworks for other medications.

The first appointment typically runs 90–180 minutes: medical history, physical exam, intake paperwork, counseling assessment, lab tests, and the first dose or prescription. Plan for 2–3 hours and arrange transportation in case of post-dose drowsiness.

First doses are intentionally cautious — 5–10 mg of buprenorphine or 20–30 mg of methadone — to assess tolerance and avoid over-sedation. Your dose is titrated up over the first 1–2 weeks until cravings and withdrawal are controlled.

Buprenorphine and methadone do not test positive on standard 5-panel drug tests — specialty panels are needed. Naltrexone and its metabolites are not screened on standard panels. Share an MAT provider letter with any employer or court drug-testing program to avoid confusion.

Yes. All Tennessee birthing hospitals are equipped to care for MAT patients. Choosing a hospital with a dedicated perinatal-addiction protocol — often larger urban hospitals — can improve experience. Discuss delivery location with your OB and MAT team well before the due date.

Patients prescribed buprenorphine or naltrexone in Tennessee can technically receive medication without counseling, but outcomes are significantly better with integrated counseling. Methadone patients at OTPs have counseling requirements per federal rule 42 CFR Part 8.

Improper disclosure of your records under 42 CFR Part 2 can be grounds for federal complaint and civil damages. File complaints with SAMHSA, the HHS Office of Civil Rights, and Tennessee’s behavioral-health licensing agency. An attorney can advise on civil remedies.